Share the post "Ganges Securities Ltd. Shareholding Update: An Examination of Financial Performance for FY (Q4-Mar 2023-2024)"
Ganges Securities Ltd. has released its latest shareholding reports, covering the quarter and the first half of the fiscal year ending on (Q4-Mar 2023-2024).This detailed report examines who owns shares, including Promoters, promoter groups, Foreign investors, public investors, and government entities.
| Shareholder Name | Previous Quater Quantity(In Crores) | Current Quater Quantity(In Crores) | Previous Quater Shares(in %) | Current Quater Shares(in %) | Quater to Quater Difference |
|---|---|---|---|---|---|
| Promoters | 0.67 | 0.67 | 66.64 | 66.64 | 0 |
| Public | 0.33 | 0.33 | 33.35 | 33.35 | 0 |
| DII | 0.00 | 0.00 | 0.01 | 0.01 | 0 |
| FII | 0 | 0 | 0 | 0 | 0 |
| Government | 0 | 0 | 0 | 0 | 0 |
Promoters shareholding remained stable, at 66.64% in both December 2023 and March 2024. This indicates that the promoters’ control over the company did not change during this period. Public shareholding remained consistent, holding steady at 33.35% in both December 2023 and March 2024. This indicates that the Public control over the company did not change during this period. DIIs (Domestic Institutional Investors) shareholding remained unchanged at 0.01% from December 2023 to March 2024. This indicates that domestic institutions maintained their investment level in the company.
Let’s look into the statistics of the investors, which could have contributed to the fluctuations in the shareholding pattern.
| Shareholder Name | Previous Quarter Quantity (In Crores) | Current Quarter Quantity (In Crores) | Previous Quater Shares (in %) | Current Quater Shares (in %) | Quater-to-Quater Difference (%) |
|---|---|---|---|---|---|
| Resident Individuals holding nominal share capital up to Rs. 2 lakhs | 0.134 | 0.143 | 13.42 | 14.26 | + 0.84 % |
| Resident Individuals holding nominal share capital in excess of Rs. 2 lakhs | 0.077 | 0.076 | 7.72 | 7.57 | -0.15 % |
| Ashok Jain | 0.013 | 0.014 | 1.27 | 1.36 | + 0.09 % |
| Non Resident Indians (NRIs) | 0.005 | 0.002 | 0.47 | 0.23 | -0.24 % |
| Bodies Corporate | 0.027 | 0.024 | 2.7 | 2.43 | -0.27 % |
| The Hindustan Times Limited | 0 | 0.012 | 0 | 1.22 | +1.22% |
| Any Other (specify) | 0.079 | 0.077 | 7.89 | 7.7 | -0.19 % |
| HUF | 0.012 | 0.010 | 1.23 | 1.05 | -0.18 % |
| Navjeewan Medical Institute | 0.062 | 0.062 | 6.22 | 6.21 | -0.01 % |
Leading the way to higher stakeholding, Resident Individuals holding nominal share capital up to Rs. 2 lakhs has significantly boosted stakeholding by an impressive 0.84 %.Observations show a significant difference of -0.15 % in Resident Individuals holding nominal share capital in excess of Rs. 2 lakhs’s financial performance between quarters.Leading the way to higher stakeholding, Ashok Jain has significantly boosted stakeholding by an impressive 0.09 %.Observations show a significant difference of -0.24 % in Non Resident Indians (NRIs)’s financial performance between quarters.Observations show a significant difference of -0.27 % in Bodies Corporate’s financial performance between quarters.Observations show a significant difference of -0.19 % in Any Other (specify)’s financial performance between quarters.Observations show a significant difference of -0.18 % in HUF’s financial performance between quarters.Observations show a significant difference of -0.01 % in Navjeewan Medical Institute’s financial performance between quarters.The Hindustan Times Limited had no shares in the previous quarter but now holds 1.22% of shares in the current quarter.
Ashok Jain, Mahendra Girdharilal, these shareholders are the Anchor investors of current and previous quarter.
14
3-Year Profit
121
5-Year Profit
0
10-Year Profit
167
Current Price
167
Market Cap
Upon examining the financial data for BSE code 540647, it becomes clear that the company achieved a notable five-year profit of 121 percents, which impressively increased to 14 percents in the three-year window. This upward trajectory, however, has been overshadowed by the latest trailing twelve-month (TTM) figures, which indicate a concerning loss of -27 percents. This financial loss is further compounded by the fact that the company has not recorded any sales across any of the timeframes under consideration. Such an unusual situation might suggest that the company operates under an unconventional business model, which could potentially carry higher risks. In terms of stock performance, the company’s stock price has seen a decline, falling from 37 percents over the five-year period to just 42 percents in the last year. The ten-year average stock price, which sits at 0 percents, highlights long-term volatility, casting doubt on the company's ability to sustain its market position over time. This warrants further investigation into the factors driving these fluctuations.
The company currently holds a market cap of ₹167 crore, with its stock trading at ₹167. Historically, the stock has fluctuated between ₹202 / 108, reflecting its performance in response to market dynamics and various economic factors. The company's Price-to-Earnings (P/E) ratio stands at 32.6, indicating that the stock is perceived as highly valued by the market, possibly driven by expectations of future earnings growth. The book value per share is ₹545, which offers insight into the company's intrinsic worth, while its dividend yield of 0.00% provides a steady return for long-term investors. Return on Capital Employed (ROCE) is 1.18%, showcasing the company’s ability to generate profits from its capital investments. Return on Equity (ROE) is 0.69%, highlighting how efficiently the company uses shareholder funds to generate profits. The debt-to-equity ratio is very low at 0.00, which is a positive indicator of financial stability. However, the company’s net cash flow of ₹-6.11 crore raises concerns about its liquidity position. The Piotroski score of 4.00 reflects the company’s overall financial health, while the Graham Number of ₹251 suggests the stock's intrinsic value. Despite these factors, the Price-to-Book (P/B) ratio of 0.31 indicates that the stock is trading at a premium to its book value, which might imply market optimism about the company's future growth prospects.
